| 摘要 |
<p>Methods and composition for modulating tolerance by altering the interaction of the T cell receptor-activated transcription factor NFAT with an NFAT-ligand, e.g., a CD28-activated transcription factor, such as AP-1 (e.g., Fos/Jun, Jun/Jun dimers) and NFλB/Rel, are described.</p> |
